Press Releases

Date	Title
August 15, 2022	Angion Provides Corporate Update and Reports Second Quarter 2022 Financial Results	PDF Version
July 25, 2022	Angion Announces Process to Explore Strategic Alternatives for Enhancing and Preserving Shareholder Value	PDF Version
June 29, 2022	Angion Announces Discontinuation of Phase 2 Trial of ANG-3070 in Patients with Primary Proteinuric Kidney Disease	PDF Version
May 16, 2022	Angion Provides Corporate Update and Reports First Quarter 2022 Financial Results	PDF Version
May 16, 2022	Angion Announces Phase 1b Trial of ANG-3070 in Patients with Idiopathic Pulmonary Fibrosis	PDF Version
May 12, 2022	Angion Announces Participation in Upcoming Investment Conference	PDF Version
April 14, 2022	Angion Announces Participation in Upcoming Investment Conference	PDF Version
March 30, 2022	Angion Provides Corporate Update and Reports Full Year 2021 Financial Results	PDF Version
February 28, 2022	Angion Announces Participation in Upcoming Investment Conferences	PDF Version
January 4, 2022	Angion Provides Corporate Update and Announces Participation in Upcoming Investor Conference	PDF Version